Genome-wide significant association with seven novel multiple sclerosis risk loci
Standard
Genome-wide significant association with seven novel multiple sclerosis risk loci. / Lill, Christina M; Luessi, Felix; Alcina, Antonio; Sokolova, Ekaterina A; Ugidos, Nerea; de la Hera, Belén; Guillot-Noël, Léna; Malhotra, Sunny; Reinthaler, Eva; Schjeide, Brit-Maren M; Mescheriakova, Julia Y; Mashychev, Andriy; Wohlers, Inken; Akkad, Denis A; Aktas, Orhan; Alloza, Iraide; Antigüedad, Alfredo; Arroyo, Rafa; Astobiza, Ianire; Blaschke, Paul; Boyko, Alexei N; Buttmann, Mathias; Chan, Andrew; Dörner, Thomas; Epplen, Joerg T; Favorova, Olga O; Fedetz, Maria; Fernández, Oscar; García-Martínez, Angel; Gerdes, Lisa-Ann; Graetz, Christiane; Hartung, Hans-Peter; Hoffjan, Sabine; Izquierdo, Guillermo; Korobko, Denis S; Kroner, Antje; Kubisch, Christian; Kümpfel, Tania; Leyva, Laura; Lohse, Peter; Malkova, Nadezhda A; Montalban, Xavier; Popova, Ekaterina V; Rieckmann, Peter; Rozhdestvenskii, Alexei S; Schmied, Christiane; Smagina, Inna V; Tsareva, Ekaterina Y; Winkelmann, Alexander; Zettl, Uwe K; Binder, Harald; Cournu-Rebeix, Isabelle; Hintzen, Rogier; Zimprich, Alexander; Comabella, Manuel; Fontaine, Bertrand; Urcelay, Elena; Vandenbroeck, Koen; Filipenko, Maxim; Matesanz, Fuencisla; Zipp, Frauke; Bertram, Lars.
in: J MED GENET, Jahrgang 52, Nr. 12, 12.2015, S. 848-855.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Genome-wide significant association with seven novel multiple sclerosis risk loci
AU - Lill, Christina M
AU - Luessi, Felix
AU - Alcina, Antonio
AU - Sokolova, Ekaterina A
AU - Ugidos, Nerea
AU - de la Hera, Belén
AU - Guillot-Noël, Léna
AU - Malhotra, Sunny
AU - Reinthaler, Eva
AU - Schjeide, Brit-Maren M
AU - Mescheriakova, Julia Y
AU - Mashychev, Andriy
AU - Wohlers, Inken
AU - Akkad, Denis A
AU - Aktas, Orhan
AU - Alloza, Iraide
AU - Antigüedad, Alfredo
AU - Arroyo, Rafa
AU - Astobiza, Ianire
AU - Blaschke, Paul
AU - Boyko, Alexei N
AU - Buttmann, Mathias
AU - Chan, Andrew
AU - Dörner, Thomas
AU - Epplen, Joerg T
AU - Favorova, Olga O
AU - Fedetz, Maria
AU - Fernández, Oscar
AU - García-Martínez, Angel
AU - Gerdes, Lisa-Ann
AU - Graetz, Christiane
AU - Hartung, Hans-Peter
AU - Hoffjan, Sabine
AU - Izquierdo, Guillermo
AU - Korobko, Denis S
AU - Kroner, Antje
AU - Kubisch, Christian
AU - Kümpfel, Tania
AU - Leyva, Laura
AU - Lohse, Peter
AU - Malkova, Nadezhda A
AU - Montalban, Xavier
AU - Popova, Ekaterina V
AU - Rieckmann, Peter
AU - Rozhdestvenskii, Alexei S
AU - Schmied, Christiane
AU - Smagina, Inna V
AU - Tsareva, Ekaterina Y
AU - Winkelmann, Alexander
AU - Zettl, Uwe K
AU - Binder, Harald
AU - Cournu-Rebeix, Isabelle
AU - Hintzen, Rogier
AU - Zimprich, Alexander
AU - Comabella, Manuel
AU - Fontaine, Bertrand
AU - Urcelay, Elena
AU - Vandenbroeck, Koen
AU - Filipenko, Maxim
AU - Matesanz, Fuencisla
AU - Zipp, Frauke
AU - Bertram, Lars
N1 - Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
PY - 2015/12
Y1 - 2015/12
N2 - OBJECTIVE: A recent large-scale study in multiple sclerosis (MS) using the ImmunoChip platform reported on 11 loci that showed suggestive genetic association with MS. Additional data in sufficiently sized and independent data sets are needed to assess whether these loci represent genuine MS risk factors.METHODS: The lead SNPs of all 11 loci were genotyped in 10 796 MS cases and 10 793 controls from Germany, Spain, France, the Netherlands, Austria and Russia, that were independent from the previously reported cohorts. Association analyses were performed using logistic regression based on an additive model. Summary effect size estimates were calculated using fixed-effect meta-analysis.RESULTS: Seven of the 11 tested SNPs showed significant association with MS susceptibility in the 21 589 individuals analysed here. Meta-analysis across our and previously published MS case-control data (total sample size n=101 683) revealed novel genome-wide significant association with MS susceptibility (p<5×10(-8)) for all seven variants. This included SNPs in or near LOC100506457 (rs1534422, p=4.03×10(-12)), CD28 (rs6435203, p=1.35×10(-9)), LPP (rs4686953, p=3.35×10(-8)), ETS1 (rs3809006, p=7.74×10(-9)), DLEU1 (rs806349, p=8.14×10(-12)), LPIN3 (rs6072343, p=7.16×10(-12)) and IFNGR2 (rs9808753, p=4.40×10(-10)). Cis expression quantitative locus effects were observed in silico for rs6435203 on CD28 and for rs9808753 on several immunologically relevant genes in the IFNGR2 locus.CONCLUSIONS: This study adds seven loci to the list of genuine MS genetic risk factors and further extends the list of established loci shared across autoimmune diseases.
AB - OBJECTIVE: A recent large-scale study in multiple sclerosis (MS) using the ImmunoChip platform reported on 11 loci that showed suggestive genetic association with MS. Additional data in sufficiently sized and independent data sets are needed to assess whether these loci represent genuine MS risk factors.METHODS: The lead SNPs of all 11 loci were genotyped in 10 796 MS cases and 10 793 controls from Germany, Spain, France, the Netherlands, Austria and Russia, that were independent from the previously reported cohorts. Association analyses were performed using logistic regression based on an additive model. Summary effect size estimates were calculated using fixed-effect meta-analysis.RESULTS: Seven of the 11 tested SNPs showed significant association with MS susceptibility in the 21 589 individuals analysed here. Meta-analysis across our and previously published MS case-control data (total sample size n=101 683) revealed novel genome-wide significant association with MS susceptibility (p<5×10(-8)) for all seven variants. This included SNPs in or near LOC100506457 (rs1534422, p=4.03×10(-12)), CD28 (rs6435203, p=1.35×10(-9)), LPP (rs4686953, p=3.35×10(-8)), ETS1 (rs3809006, p=7.74×10(-9)), DLEU1 (rs806349, p=8.14×10(-12)), LPIN3 (rs6072343, p=7.16×10(-12)) and IFNGR2 (rs9808753, p=4.40×10(-10)). Cis expression quantitative locus effects were observed in silico for rs6435203 on CD28 and for rs9808753 on several immunologically relevant genes in the IFNGR2 locus.CONCLUSIONS: This study adds seven loci to the list of genuine MS genetic risk factors and further extends the list of established loci shared across autoimmune diseases.
U2 - 10.1136/jmedgenet-2015-103442
DO - 10.1136/jmedgenet-2015-103442
M3 - SCORING: Journal article
C2 - 26475045
VL - 52
SP - 848
EP - 855
JO - J MED GENET
JF - J MED GENET
SN - 0022-2593
IS - 12
ER -